文献速递瓣膜外科

心脏植入式电子装置患者三尖瓣反流的外科治疗:长期结果

Surgical treatment of tricuspid valve regurgitation in patients with cardiac implantable electronic devices: long-term results.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

该回顾性研究纳入2000至2019年本院既往植入心脏植入式电子装置(CIED)并接受三尖瓣修复或置换的151例患者,其中103例(68%)为CIED所致三尖瓣反流,48例(32%)为CIED相关三尖瓣反流;105例接受三尖瓣修复,46例接受三尖瓣置换;在修复患者中,CIED所致与CIED相关三尖瓣反流的中度反流复发率无显著差异。

要点

  • CIED患者外科治疗的三尖瓣反流中约三分之二为CIED所致,三分之一为CIED相关。
  • 本研究中63%的病例仍可行三尖瓣修复。
  • 修复患者中CIED所致与CIED相关三尖瓣反流的中度反流复发率无显著差异。

核心结论

  • 在CIED并接受外科治疗的三尖瓣反流患者中,三尖瓣反流约三分之二为CIED所致,三分之一为CIED相关;本经验中63%的病例仍可行三尖瓣修复,长期结果良好,且CIED所致与CIED相关三尖瓣反流之间耐久性无显著差异。

研究设计与样本

  • 回顾性审查本院数据库,选取2000年至2019年间既往植入CIED并接受三尖瓣修复和置换的所有患者,共151例。
  • 采用Kaplan-Meier法分析长期生存,并使用广义估计方程对三尖瓣反流的时间过程进行纵向分析。

主要发现

  • 共识别151例患者,其中103例(68%)检出机械性干扰瓣叶活动与对合(CIED所致组),其余48例(32%)导线与三尖瓣反流相关但非其病因(CIED相关组)。
  • 105例患者接受三尖瓣修复,其余46例需要三尖瓣置换。
  • 在接受三尖瓣修复的患者中,CIED所致与CIED相关三尖瓣反流之间中度三尖瓣反流复发率无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: With the expanding use of cardiac implantable electronic devices (CIEDs), lead interference with the tricuspid valve (TV) causing significant tricuspid regurgitation (TR) has gained increasing recognition. However, current knowledge about the long-term results of the surgical treatment of TR in this setting is scanty. Therefore, increasing this information was the goal of this study. METHODS: A retrospective review of our institutional database was carried out to select all patients with previously implanted CIEDs who underwent tricuspid valve repair and replacement from 2000 through 2019. Kaplan-Meier methods were used to analyse long-term survival. To describe the time course of TR, we performed a longitudinal analysis using generalized estimating equations. RESULTS: A total of 151 patients were identified. Mechanical interference with leaflet mobility and coaptation was detected in 103 patients (68%) (CIED-induced group); in the remaining 48 patients (32%), the lead was associated with TR without being the cause of it (CIED-associated group). A total of 105 patients underwent TV repair; in the remaining 46, a TV replacement was necessary. In patients who underwent TV repair, no significant difference in moderate TR recurrence rate was highlighted between CIED-induced and CIED-associated TR. CONCLUSIONS: In patients with CIEDs and surgically treated tricuspid regurgitation, TR is CIED-induced in about two-thirds of the cases and CIED-associated in one-third of them. In our experience, TV repair was still possible in 63% of the cases, with good long-term results and no significant durability difference between CIED-induced and CIED-associated TR.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Carino D, Sala A, Zancanaro E, et al. Surgical treatment of tricuspid valve regurgitation in patients with cardiac implantable electronic devices: long-term results. Eur J Cardiothorac Surg. 2022. PMID: 35426906. doi:10.1093/ejcts/ezac239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。